about
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.Maternal immune correlates of protection against placental transmission of cytomegalovirus.Elastic and viscoelastic characterization of agar.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infectionHCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functionsIntrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccineesHCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunizationIntrahost cytomegalovirus population genetics following antibody pretreatment in a monkey model of congenital transmissionImmune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and DiseaseHigh-resolution micro-epidemiology of parasite spatial and temporal dynamics in a high malaria transmission setting in Kenya
P50
Q33877783-E29F9702-11B0-41B0-8855-6E32E713B620Q38744569-B0B2E0F6-9E3C-4DD3-9A34-C77354A086D7Q38908361-7A025F95-4835-48F3-959C-F00A0BC2B25EQ39272221-CF5477C2-4080-4D0F-9E90-2BF4B5D24BB4Q46639122-6857E038-4781-4810-BA03-ACF11514F597Q57072187-1D41C22A-09E6-4D0E-8DB6-65F861641963Q59349089-F3B2138C-E106-4F49-B5BC-4135F6B8BA98Q60031666-672F0325-C199-41E5-9736-9B837CBBAA8DQ89685617-61BC7097-49BF-490A-AE76-C17A084950B1Q89717809-CF5EA8A8-0FC2-4F8E-843D-92389E207819Q90062898-AA2D888C-7809-4113-ACF3-76A22EEED8E4Q91825303-6EE6FA51-E516-40D3-85CA-BC35416D7A54
P50
description
investigador
@es
researcher
@en
name
C S Nelson
@en
type
label
C S Nelson
@en
prefLabel
C S Nelson
@en
P31
P496
0000-0002-1046-455X